Subscribe to MDT Magazine News

OrbusNeich Announces Availability of Azuleâ„¢ Cobalt Chromium Stent

March 14, 2011 6:34 am | by Bio-Medicine.Org | Comments

HONG KONG, March 14, 2011 /- OrbusNeich today announced the launch of the CE marked Azule Cobalt Chromium Stent.  The Azule Stent combines the proven stent design of its predecessor, the company's Blazer™ Cobalt Chromium Stent, with a delivery system with enhanced crossability...


Transgenomic Expands COLD-PCR License

March 14, 2011 6:33 am | by Bio-Medicine.Org | Comments

OMAHA, Neb., March 14, 2011 /- Transgenomic, Inc. (OTC Bulletin Board: TBIO ) today announced the completion of an expanded license with the Dana-Farber Cancer Institute, Boston, MA, for the COLD-PCR (CO-amplification at Lower Denaturing temperature PCR) technology. Previously,...


BIOLASE to Present at the ROTH OC Growth Stock Conference in Dana Point, CA

March 14, 2011 5:45 am | by The Associated Press | Comments

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that management is scheduled to make an investor presentation at the ROTH 23rd Annual Growth Stock Conference on Wednesday, March 16, at 2:30 pm Pacific Time. The...


Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer

March 14, 2011 4:37 am | by Bio-Medicine.Org | Comments

CINCINNATI, March 14, 2011 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a market leading provider of document workflow solutions for hospitals, announced today that Rick Leach has been appointed Senior Vice President and Chief Marketing Officer effective March 14, 2011. With more...


Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators

March 14, 2011 4:34 am | by Bio-Medicine.Org | Comments

BEIJING, March 14, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has...


Covidien Announces New Data on Hernia and Abdominal Wall Repair Products to Be Presented at Hernia Repair 2011

March 14, 2011 3:32 am | by Covidien | Comments

Surgeons to unveil updated results of clinical trials for hernia repair at American Hernia Society's Annual Meeting NORTH HAVEN, Conn., Mar 14, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, announced that new data on its hernia and...


FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium

March 14, 2011 2:36 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., March. 14, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a...


LaVoie Group Wins Two Mercury Excellence Awards

March 14, 2011 2:36 am | by Bio-Medicine.Org | Comments

SALEM, Mass., March 14, 2011 /- LaVoie Group, the acknowledged leader in life science and pharmaceutical communications, announced today that it has received a Gold Award in the 24th Annual International Mercury Excellence Awards 2010/2011 competition, given annually by MerComm, Inc....


Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology

March 14, 2011 12:32 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., March 14, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB (formerly Tripep AB), has initiated a Phase...


Santarus Stockholders Get Their Share of Disappointing News

March 13, 2011 11:35 pm | by San Diego Business Journal | Comments

Santarus Inc. stockholders weren't exactly hopping for joy after the U.S. Food and Drug Administration declined approval Feb. 26 of a product based on a new treatment for hereditary angioedema, or swelling of the face and airways, derived from rabbit's milk.


Opportunity for Expansion Rises in Far East for Life Sciences Company

March 13, 2011 11:34 pm | by San Diego Business Journal | Comments

Life Technologies Corp. has joined a growing group of local biotech firms continuing to invest in Asia. The Carlsbad company announced that it has opened a 62,300-square-foot distribution center


Taking tamoxifen to prevent breast cancer can save lives and money

March 13, 2011 9:33 pm | by EurekAlert | Comments

(Wiley-Blackwell) Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results...


Tolerx, GSK diabetes drug candidate misses goal

March 13, 2011 8:37 pm | by Mass High Tech: The Journal of New England Technology | Comments

A Phase 3 clinical study of a type 1 diabetes treatment by Cambridge biotech Tolerx Inc., in conjunction with British pharmaceutical giant GlaxoSmithKline, failed to meet its primary endpoint.

Department of Energy announces funding to support the next generation of American scientists and engineers

March 13, 2011 8:37 pm | by I-Micronews | Comments

Fellowship programs to support innovative research and ensure U.S. leadership in clean energy.

A New Approach to Treating Rheumatoid Arthritis

March 13, 2011 8:36 pm | by Massachusetts Institute of Technology | Comments

An engineered protein reduces arthritis symptoms in mice.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.